MedCity News

FEBRUARY 4, 2025

VR allows learners to actually see the virtual germs responsible for causing infections and spreading disease, which could otherwise only be seen under a microscope. The technology also heightens users’ senses, drawing their attention to things they would be unable to see in traditional learning environments. The post The Future of Training: How Virtual Reality Can Protect Clinicians from Healthcare-associated Infections appeared first on MedCity News.

Training 300

Training Healthcare Healthcare Education 300

Infuse Medical

FEBRUARY 4, 2025

In todays rapidly advancing healthcare landscape, the demands placed on medical professionals are greater than ever. With new medical devices, surgical techniques, and treatment protocols emerging constantly, the need for effective, efficient, and scalable training methods has become paramount. Traditional approachestextbooks, live demonstrations, and hands-on workshopswhile valuable, are no longer sufficient to meet the complexities of modern healthcare.

Training 130

Training Medical Healthcare Healthcare 130

Evolve Your Success

FEBRUARY 5, 2025

From navigating the halls of Abbott Laboratories and Knoll Pharmaceutical Company to pioneering his path as an independent medical device sales rep, Bruce Brown’s career journey challenges traditional sales wisdom. In this episode, he reveals the innovative strategies that helped him thrive in both worlds – including an ingenious FedEx tactic that changed his pharmaceutical sales game.

Sales 130

Sales Medical sales Pharma Medical 130

PharmaVoice

FEBRUARY 3, 2025

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are coming through the pipes if it does.

217

217

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

MedCity News

FEBRUARY 2, 2025

Investors showed appetite for Metseras IPO, as shares of the clinical-stage metabolic medicines biotech popped 47% in their Nasdaq debut. Maze Therapeutics and Beta Bionics also priced IPOs; the three companies raised $636 million combined. The post Metseras IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s appeared first on MedCity News.

Medicine 292

Medicine Biopharma Pharma 292

David Bagga

FEBRUARY 1, 2025

Break into Medical device Sales What are the career opportunities after medical sales college? Are you considering enrolling in a medical sales college or completing your medical sales course now? What’s next? Relax if you’re thrilled but perhaps nervous about your next move. The medical sales field is rich in possibilities. You can have an […] The post career opportunities after medical sales college appeared first on.

Medical sales 130

Medical sales Sales Medical 130

PharmaVoice

FEBRUARY 7, 2025

While the 10% tariff on Chinese goods won’t have too much impact on branded drugs, generics are struggling to pivot.

173

173

MedCity News

FEBRUARY 5, 2025

Novo Nordisks monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity. The post Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects appeared first on MedCity News.

Side effects 277

Side effects Biopharma Pharma 277

European Pharmaceutical Review

FEBRUARY 4, 2025

Two years after signing its strategic partnership with the UK government, Moderna, Inc. has made substantial R&D investment and progress in the UK, the company has declared. The Moderna Innovation and Technology Centre (MITC) began construction in April 2023 as the companys state-of-the-art R&D and manufacturing facility. [Moderna] was the biggest industry sponsor of clinical trials in the UK in 2023/24″ The site is anticipated to be fully operational later in 2025, ready to delive

Government 71

Government Manufacturing Leads Pharmaceutical 71

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmaceutical Technology

FEBRUARY 7, 2025

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.

Pharma 104

Pharma Healthcare Healthcare 104

PharmaVoice

FEBRUARY 7, 2025

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and around 1,000 prescriptions weekly by late January.

Prescription 130

Prescription Sales 130

MedCity News

FEBRUARY 7, 2025

Bain Capitals buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma appeared first on MedCity News.

Pharma 257

Pharma Pharmaceutical Biopharma 257

European Pharmaceutical Review

FEBRUARY 5, 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) is seeking feedback on its regulatory guidance for individualised mRNA cancer immunotherapies. This guidance aims to streamline access pathways for patients, without compromising on the safety of these personalised immunotherapies. These cancer vaccines are tailored to an individuals tumour, [so] they pose unique scientific questions on how they should be regulated, Julian Beach , MHRA Executive Director of Healthcare Quality and Acc

Food and Drug Administration 52

Food and Drug Administration Government Safety Medicine 52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Technology

FEBRUARY 3, 2025

Sanofi has received Chinas NMPA approval for the use of Sarclisa, combined with a standard-of-care regimen, for treating adults with NDMM.

104

104

PharmaVoice

FEBRUARY 6, 2025

The market has been no less demanding for pharma giants as 2025 begins, but last year’s strategies are paying off.

Pharma 130

Pharma Marketing 130

MedCity News

FEBRUARY 6, 2025

Currently available therapies for Hunter syndrome dont cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denalis Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval appeared first on MedCity News.

FDA 254

FDA Biopharma Pharma 254

PharmaTimes

FEBRUARY 3, 2025

Funding led by new investors FSG and EIC Fund

102

102

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

FEBRUARY 4, 2025

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

100

100

PharmaVoice

FEBRUARY 3, 2025

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?

Patients 130

Patients Healthcare Healthcare Medical 130

MedCity News

FEBRUARY 2, 2025

As the pharmaceutical landscape evolves, small-molecule CDMOs will be essential in balancing supply and demand, driving innovation, and improving patient outcomes. They must continue embracing innovation and strategic agility to survive and thrive in this complex environment. The post Building Resilience: CDMO Strategies for Drug Supply Chain Stability appeared first on MedCity News.

Pharmaceutical 259

Pharmaceutical Patients Biopharma Pharma 259

PharmaTimes

FEBRUARY 3, 2025

Positive opinion issued for marketing authorisation extension

Patients 101

Patients Marketing 101

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

David Bagga

FEBRUARY 5, 2025

Break into Medical device Sales 6 Common challenges in medical device sales Medical device sales isa rewarding and high paying career, but there can be some hurdles to jumping into this field. It is helpful to know what you can expect when yourenew to the medical device sales industry or are interested in becoming part […] The post 6 Common challenges in medical device sales appeared first on.

100

100

PharmaVoice

FEBRUARY 5, 2025

With assets under a knife and pipelines under a microscope, R&D programs are being overhauled to be more efficient and cost effective.

Pharma 100

Pharma 100

MedCity News

FEBRUARY 4, 2025

LLMs, with their remarkable conversational abilities, are uniquely positioned to help solve this crisis. But as with the dotcom boom before it, the surge of AI ‘therapists’ has created a turbulent landscape where separating legitimate innovation from dangerous shortcuts isn’t straightforward. The post Patient-Facing AI: Separating Signal from Noise appeared first on MedCity News.

Patients 185

Patients Healthcare Healthcare 185

PharmaTimes

FEBRUARY 5, 2025

Breast cancer therapy offers hope for patients at risk of recurrence

Patients 100

Patients 100

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmaceutical Technology

FEBRUARY 7, 2025

Sanofi has agreed to purchase its own shares worth 2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.

Pharma 98

Pharma 98

pharmaphorum

FEBRUARY 4, 2025

After setbacks with psychedelics, phase 2b data with GH Research's GH001 for treatment-resistant depression could lift confidence in the category

94

94

MedCity News

FEBRUARY 4, 2025

Supernus Pharmaceuticals Onapgo provides a continuous infusion of apomorphine to manage off periods experienced by Parkinsons disease patients. Approval of Onapgo comes after the FDA twice turned back applications for the drug/device combination product. The post Supernus Wearable Device for Dosing Parkinsons Drug Lands Long-Awaited FDA Approval appeared first on MedCity News.

FDA 184

FDA Pharmaceutical Management Patients 184